Lipid alterations in transient forebrain ischemia: Possible new mechanisms of CDP-choline neuroprotection

Journal of Neurochemistry

Volumn 75, Issue 6, 2000, Pages 2528-2535

  Rao, A Muralikrishna ^a   Hatcher, J F ^a   Dempsey, R J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Arachidonic acid; CA1 neuronal death; Cardiolipin; Ceramide; Citicoline; Glutathione; Mitochondria; Phosphatidylch oline; Phosphatidylethanolamine; S Adenosyl L methionine; Sphingomyelin

Indexed keywords

ARACHIDONIC ACID; CARDIOLIPIN; CERAMIDE; CITICOLINE; ICOSANOID; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; PHOSPHOLIPID; REACTIVE OXYGEN METABOLITE; SPHINGOMYELIN PHOSPHODIESTERASE;

AEROBIC METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DRUG EFFECT; FOREBRAIN; GERBIL; LIPID ANALYSIS; MALE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL;

ANIMALS; ARACHIDONIC ACID; CARDIOLIPINS; CERAMIDES; CYTIDINE DIPHOSPHATE CHOLINE; GERBILLINAE; ISCHEMIC ATTACK, TRANSIENT; MALE; NEUROPROTECTIVE AGENTS; PHOSPHATIDYLCHOLINES; PHOSPHATIDYLETHANOLAMINES; PHOSPHATIDYLINOSITOLS; PHOSPHATIDYLSERINES; PHOSPHOLIPIDS; PROSENCEPHALON; REPERFUSION; SPHINGOMYELINS;

ANIMALIA; GERBILLINAE;

EID: 0033777506     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0752528.x     Document Type: Article

References (74)

1. Oral cytidine 5'-diphosphate choline administration to rats increases brain phospholipid levels
2. Citicoline protects hippocampal neurons against apoptosis induced by brain β-amyloid deposits plus cerebral hypoperfusion in rats
3. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model
4. Glutamate induced cell death: Apoptosis or necrosis?
5. Citicoline for treatment of experimental focal ischemia: Histologic and behavioral outcome
6. 2 and cholinephosphotransferase activities following a cryogenic brain injury in the rabbit
7. Reduced glutathione oxidation ratio and 8 ohdG accumulation by mild ischemic pretreatment
8. Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury
9. Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brain
10. The neuromessenger platelet-activating factor in plasticity and neurodegeneration
11. Small differences in intra-ischemic brain temperature critically determine the extent of ischemic neuronal injury
12. Superoxide in apoptosis. Mitochondrial generation triggered by cytochrome c loss
13. Mitochondrial control of apoptosis: The role of cytochrome c
14. Protein-bound acrolein: A novel marker of oxidative stress in Alzheimer's disease
15. Methods for antagonizing glutamate neurotoxicity
16. Clinical trials with neuroprotective drugs in acute ischaemic stroke: Are we doing the right thing?
17. Effects of CDP-choline treatment on neurobehavioral deficits after TBI and on hippocampal and neocortical acetylcholine release
18. Citicoline (CDP-choline): Mechanisms of action and effects in ischemic brain injury
19. Effects of CDP-choline and CDP-ethanolamine on the alterations in rat brain lipid metabolism induced by global ischemia
20. 2 and its role in brain tissue
21. Mitochondrial glutathione: Importance and transport
22. Mitochondria in neurodegeneration: Acute ischemia and chronic neurodegenerative diseases
23. Presynaptic facilitation of glutamate release from isolated hippocampal mossy fiber nerve endings by arachidonic acid
24. Biochemical rationale for the use of CDP-choline in traumatic brain injury: Pharmacokinetics of the orally administered drug
25. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione
26. Ceramide induces cytochrome c release from isolated mitochondria. Importance of mitochondrial redox state
27. Effects of CDP-choline administration on brain striatum platelet-activating factor in aging rats
28. Cytidine diphosphate choline administration activates brain cytidine triphosphate: Phosphocholine cytidylyltransferase in aged rats
29. Does ceramide play a role in neural cell apoptosis?
30. The central executioners of apoptosis: Caspases or mitochondria?
31. Mitochondria and apoptosis
32. Ceramide: An intracellular signal for apoptosis
33. Cardiolipins and biomembrane function
34. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor α
35. Reperfusion injury after focal cerebral ischemia: The role of inflammation and the therapeutic horizon
36. Arachidonic acid as a neurotoxic and neurotrophic substance
37. The pharmacology of apoptosis
38. Enhancement of free fatty acid incorporation into phospholipids by choline plus cytidine
39. Ceramide: A signal for apoptosis or mitogenesis?
40. Ceramide and apoptosis
41. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis
42. Accumulation of ceramide in ischemic human brain of an acute case of cerebral occlusion
43. Sphingomyelin changes in rat cerebral cortex during focal ischemia
44. Signalling sphingomyelinases: Which, where, how and why?
45. Ischemic cell death in brain neurons
46. Advances in the signal transduction of ceramide and related sphingolipids
47. Evidence that 5'-cytidinediphosphocholine can affect brain phospholipid composition by increasing choline and cytidine plasma levels
48. Regulation of hepatic glutathione synthesis: Current concepts and controversies
49. Signal transduction of stress via ceramide
50. Role of oxygen free radicals and lipid peroxidation in cerebral reperfusion injury
51. Degradation of mitochondrial phospholipids during experimental cerebral ischemia in rats
52. Changes in major phospholipids of mitochondria during postischemic reperfusion in rat brain
53. Synergistic effects of citicoline and MK-801 in temporary experimental focal ischemia in rats
54. The role of ceramide in cell signaling
55. Beneficial effects of S-adenosyl-L-methionine on blood-brain barrier breakdown and neuronal survival after transient cerebral ischemia in gerbils
56. CDP-choline: Neuroprotection in transient forebrain ischemia of gerbils
57. Lipid metabolism in ischemic neuronal death
58. 4: Role in transient cerebral ischemia of gerbils
59. Neuroprotection by group I metabotropic glutamate receptor antagonists in forebrain ischemia of gerbil
60. Regulation of phosphoinositide-specific phospholipase C isozymes
61. Increased surface phosphatidylserine is an early marker of neuronal apoptosis
62. 2+ availability in isolated mossy fiber nerve endings
63. Early increases in TNF-α, I1-6 and I1-1-β levels following transient cerebral ischemia in gerbil brain
64. Apoptosis and the nervous system
65. Synergistic effects of a combination of low-dose basic fibroblast growth factor and citicoline after temporary experimental focal ischemia
66. CDP-choline: Pharmacological and clinical review
67. Evaluating the efficacy of citicoline in embolic ischemic stroke in rats: Neuroprotective effects when used alone or in combination with urokinase
68. Studies in vitro on the biosynthesis of ceramide and sphingomyelin. A reevaluation of proposed pathways
69. Oral administration of soybean lecithin transphosphatidylated phosphatidylserine (SB-tPS) reduces ischemic damage in the gerbil hippocampus
70. Effect of CDP-choline on ischemia-induced alterations of brain lipid in the gerbil
71. The effect of S-adenosyl-L-methionine (SAM) on ischemia induced disturbances of brain phospholipid in the gerbil
72. Protein-bound acrolein: Potential markers for oxidative stress
73. Relationships between phosphatidylcholine, phosphatidylethanolamine, and sphingomyelin metabolism in cultured oligodendrocytes
74. Metabolism and actions of CDP-choline as an endogenous compound and administered exogenously as citicoline